Residual Inflammatory Risk and the Impact on Clinical Outcomes in Patients after Percutaneous Corona (IMAGE)

European Society of Cardiology

Residual Inflammatory Risk and the Impact on Clinical Outcomes in Patients after Percutaneous Corona

Caption

Take home figure: Concept of residual inflammatory risk and the main findings of this study. High high sensitive C-reactive protein is defined as >2 mg/L. aAdjusted for age, gender, body mass index, acute coronary syndrome, diabetes mellitus, hypertension, chronic kidney disease, previous coronary artery bypass graft, and baseline low-density lipoprotein cholesterol. Red hazard ratio indicates a P-value <0.01. MACE, major adverse cardiovascular events, composite of death, MI, and CVA; MACEþ, MACE with any revascularization; MI, myocardial infarction.

Credit

Roxana Mehran, Mount Sinai Medical Center, New York, USA

Usage Restrictions

If used, please credit Roxana Mehran, Mount Sinai Medical Center, New York, USA, and the European Heart Journal

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.